Mayors Committee on Life Sciences Patient Courage Award Given to Passaic Deputy Mayor Minnie Hiller
Statement on the U.S.-Mexico-Canada Agreement from Dean J. Paranicas, HINJ President and Chief Executive Officer
“The HealthCare Institute of New Jersey (HINJ) and its member companies applaud the proposed United States-Mexico-Canada Agreement on trade for strengthening intellectual property protections that will reinforce America’s global leadership in research and development. These protections will enable the continued medical innovation that is the lifeblood of our biopharmaceutical and medical technology community. We are hopeful for similar agreements in the future that expand the horizons for medical innovation in other parts of the world.”
HINJ Honors Innovative Program at the New Jersey Institute of Technology
HINJ recently presented its 2018 Life Sciences Recognition Award for Innovation to the Garden Practice Transformation Network, a unit of the Healthcare Delivery Systems iLab, “in recognition of contributions and leadership in improving healthcare delivery and patient outcomes.”
The network has more than 10,000 physicians and has achieved more than $138 million in savings, so far. The iLab is part of the New Jersey Innovation Institute at the New Jersey Institute of Technology.
The presentation was made September 27, at the annual DV/NJ Healthcare Information Management Systems Society Fall Event.
You can read more about the iLab in a recent ROI-NJ story.
We Work For Health New Jersey Team Participates in 2018 National Summit
HealthCare Institute of New Jersey Announces New Board and Steering Committee Leadership
The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1.
Alex Kelly, who is Executive Vice President, Corporate Affairs, Allergan, has been elected Chair of the HINJ Board of Trustees. He previously served as Treasurer.
Mr. Kelly has been an EVP and the Chief Communications Officer at Allergan since 2015. Previously, he served as Senior Vice President, Chief Integration Officer since July 2014. In this role, he led the integration of Forest Laboratories and co-led the integration of Allergan, Inc. following Actavis’ acquisition of each company. Prior to joining Actavis, Mr. Kelly was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Laboratories. Previously, Mr. Kelly served as Vice President, Investor Relations at Bausch + Lomb and he was Senior Vice President, Investor Relations at Merck & Co., Inc. He earned his Bachelor of Science in Pharmacy from Purdue University, where he graduated Cum Laude.
Mr. Kelly succeeds Yin Becker, Vice President, Communications and Public Affairs, Stryker. Ms. Becker continues to serve HINJ as Immediate Past Chair.
Also at its May 15 meeting, the HINJ Board elected Dan Casserly, U.S. Country Head, Government Affairs, Novartis Services, Inc., to serve as Vice Chair. The new Treasurer is Steven Immergut, Vice President and Head of Communications and Advocacy Relations, Pharmaceuticals, Bayer. Lisa M. Goldman continues to serve as Board Secretary.
HINJ also has announced that Loredana Cromarty, Associate Vice President, Government Affairs, Allergan, has been appointed Chair of the HINJ Steering Committee. The new Vice Chair is Wendy Lazarus, Director, State Government Relations, Pfizer, Inc.
ALSIC Honors Rep. Bonnie Watson Coleman
HINJ Media Contact:
Edward F. Tate III
Director of Communications
732-729-9619, ext. 344